NEW YORK, NY / ACCESSWIRE / April 27, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Athenex, Inc. (NASDAQ:ATNX)
Class Period: August 7, 2019 - February 26, 2021
Lead Plaintiff Deadline: May 3, 2021

The ATNX lawsuit alleges Athenex, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company's NDA in its current form; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in ATNX: http://www.kleinstocklaw.com/pslra-1/athenex-inc-loss-submission-form?id=15183&from=1

CytoDyn Inc. (OTCQB:CYDY)
Class Period: March 27, 2020 - March 9, 2021
Lead Plaintiff Deadline: May 17, 2021

During the class period, CytoDyn Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.

Learn about your recoverable losses in CYDY: http://www.kleinstocklaw.com/pslra-1/cytodyn-inc-loss-submission-form?id=15183&from=1

Neptune Wellness Solutions Inc. (NASDAQ:NEPT)
Class Period: July 24, 2019 - February 16, 2021
Lead Plaintiff Deadline: May 17, 2021

The complaint alleges that throughout the class period Neptune Wellness Solutions Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in NEPT: http://www.kleinstocklaw.com/pslra-1/neptune-wellness-solutions-inc-loss-submission-form?id=15183&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com:
https://www.accesswire.com/642495/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-ATNX-CYDY-and-NEPT